eGFP mRNA (Cap1, m1??) 0.2mg

The University of Virginia has awarded contract A207_PO-0473876 to GenScript ProBio USA Inc., effective August 27, 2026. The cumulative contract value is $350. While the specific products and services to be delivered under this purchase order are not detailed in the available documentation, GenScript ProBio USA Inc. is a biotechnology services provider, suggesting the work likely involves molecular biology, protein production, or related scientific services commonly provided to academic research institutions.

The contract does not specify a defined period of performance, place of performance, or annual value beyond the cumulative total. As a purchase order issued by an academic institution in Virginia, this award represents a commitment by the University of Virginia to procure services or materials from the contractor. Additional contract documentation would be necessary to clarify the specific deliverables, performance timeline, and detailed scope of work associated with this procurement action.